$SNTA MADRIGAL PHARMACEUTICALS, INC. Insider Trading Week 26/2014
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in MADRIGAL PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in MADRIGAL PHARMACEUTICALS, INC. in week 26/2014.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Option Exercise | A | 4.10 | 10,000 | 41,000 | 10,000 | |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Grant | A | 0.00 | 1,219 | 0 | 3,060,860 | 3.1 M to 3.1 M (+0.04 %) |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Grant | A | 0.00 | 1,219 | 0 | 3,059,641 | 3.1 M to 3.1 M (+0.04 %) |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Kovner Bruce | Director | Grant | A | 0.00 | 9,756 | 0 | 3,058,422 | 3 M to 3.1 M (+0.32 %) |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | FRIEDMAN PAUL A | Director | Option Exercise | A | 4.10 | 10,000 | 41,000 | 10,000 | |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Option Exercise | A | 4.10 | 4,500 | 18,450 | 4,500 | |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Option Exercise | A | 4.10 | 10,000 | 41,000 | 10,000 | |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 1,219 | 0 | 351,766 | 350.5 K to 351.8 K (+0.35 %) |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 1,219 | 0 | 350,547 | 349.3 K to 350.5 K (+0.35 %) |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 2,439 | 0 | 349,328 | 346.9 K to 349.3 K (+0.70 %) |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 4,878 | 0 | 346,889 | 342 K to 346.9 K (+1.43 %) |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | Gollust Keith R | Director | Grant | A | 0.00 | 9,756 | 0 | 342,011 | 332.3 K to 342 K (+2.94 %) |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Option Exercise | A | 4.10 | 10,000 | 41,000 | 10,000 | |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | REARDON WILLIAM S | Director | Grant | A | 0.00 | 4,878 | 0 | 41,439 | 36.6 K to 41.4 K (+13.34 %) |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | KUFE DONALD W | Director | Option Exercise | A | 4.10 | 10,000 | 41,000 | 10,000 | |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | WILSON ROBERT N | Director | Option Exercise | A | 4.10 | 10,000 | 41,000 | 10,000 | |
| Jul 03 2014 | SNTA | SYNTA PHARMACEUTIC ... | WILSON ROBERT N | Director | Grant | A | 0.00 | 2,439 | 0 | 704,118 | 701.7 K to 704.1 K (+0.35 %) |